Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ko Nakajo"'
Autor:
Ko Nakajo, Hiroshi Nishiura
Publikováno v:
International Journal of Infectious Diseases, Vol 124, Iss , Pp 14-20 (2022)
Objectives: Elucidating the infection dynamics that lead to severe respiratory syncytial virus (RSV) pneumonia and hospitalization among young children are critical. We explored the role of infection parity as well as age in months for RSV-associated
Externí odkaz:
https://doaj.org/article/77effe2260a9450f93fe09ccd8065fce
Autor:
Ko Nakajo, Hiroshi Nishiura
Publikováno v:
Epidemics, Vol 38, Iss , Pp 100545- (2022)
R(t), the actual average number of secondary cases per primary case at calendar time t, is epidemiologically useful in assessing transmission dynamics in a population with varying susceptibility levels. However, a technical limitation of existing met
Externí odkaz:
https://doaj.org/article/f601ffbcf670414184281cbdfbcc9250
Autor:
Ko Nakajo, Hiroshi Nishiura
Publikováno v:
International Journal of Infectious Diseases, Vol 105, Iss , Pp 236-238 (2021)
Background: The epidemiological importance of asymptomatic individuals who would never develop illness, compared to those who eventually develop symptoms, has yet to be fully clarified. Methods: The very first cluster data in Tokyo and Kanagawa (n =
Externí odkaz:
https://doaj.org/article/e7863bac854d4a4e81522fc00c715914
Autor:
Hiroshi Nishiura, Ko Nakajo
Publikováno v:
Theoretical Biology and Medical Modelling, Vol 18, Iss 1, Pp 1-8 (2021)
Theoretical Biology & Medical Modelling
Theoretical Biology & Medical Modelling
Background Individuals with asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can propagate the virus unknowingly and thus have been a focus of public health attentions since the early stages of the pandemic. Underst
Autor:
Hiroshi Nishiura, Ko Nakajo
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 105, Iss, Pp 236-238 (2021)
International Journal of Infectious Diseases, Vol 105, Iss, Pp 236-238 (2021)
Background The epidemiological importance of asymptomatic individuals who would never develop illness, compared to those who eventually develop symptoms, has yet to be fully clarified. Methods The very first cluster data in Tokyo and Kanagawa (n = 36
Autor:
Ko Nakajo, Hiroshi Nishiura
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 6
Journal of Clinical Medicine, Vol 10, Iss 1256, p 1256 (2021)
Volume 10
Issue 6
Journal of Clinical Medicine, Vol 10, Iss 1256, p 1256 (2021)
Estimation of the effective reproduction number, R(t), of coronavirus disease (COVID-19) in real-time is a continuing challenge. R(t) reflects the epidemic dynamics based on readily available illness onset data, and is useful for the planning and imp
To understand the current state of treatment patterns and health care resource utilization among patients in Japan with ankylosing spondylitis (AS) managed in the real-world setting. Patient records from the Medical Data Vision database were analyzed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82a92362c1919805aa4b23c95e1c495
Autor:
Hidehisa Saeki, Yoshinori Umezawa, Hitoe Torisu-Itakura, H. Elmaraghy, Yoji Morisaki, Ko Nakajo, N Akashi
Publikováno v:
Journal of the European Academy of Dermatology and Venereology
Background Long‐term management of moderate‐to‐severe psoriasis is usually discussed in terms of continuous administration; however, there are many situations in clinical practice where treatment may be withdrawn with subsequent retreatment. Ob
Autor:
Keiji Iwatsuki, H. Elmaraghy, Yoji Morisaki, Yukari Okubo, Ko Nakajo, Hitoe Torisu-Itakura, Tomotaka Mabuchi
Publikováno v:
Journal of the European Academy of Dermatology and Venereology
Background Erythrodermic and generalized pustular psoriasis are rare, difficult to treat forms of psoriasis. In previous reports, we documented 24‐ and 52‐week findings of an open‐label, phase 3 trial (UNCOVER‐J) of ixekizumab in Japanese pat
Autor:
Ko Nakajo, Levent Alev, Hitoshi Yasuda, Nigishi Hotta, Tadaaki Yamada, Masato Kasuga, Yuko Baba, Atsunori Kashiwagi, Ryuzo Kawamori
Publikováno v:
Journal of Diabetes Investigation
Introduction To examine the long‐term efficacy and safety of duloxetine in the treatment of Japanese patients with diabetic neuropathic pain, we carried out a 52‐week, randomized, open‐label extension of a 12‐week, double‐blind, placebo‐c